Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
SGLT2 Inhibitors Lower T2D Risk in People With Heart Failure
TOPLINE: Treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) was associated with a reduced incidence of type 2 diabetes (T2D), all-cause mortality, and heart failure (HF)-related adverse outcomes. METHODOLOGY: A retrospective cohort analysis of TriNetX patients with HF, without baseline diabetes,…
English